MedTrace Logo

Multicentre LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness (LOGIC-2)

NCT02056353 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1550

Last updated 2016-01-08

No results posted yet for this study

Summary

Most critically ill patients are confronted with hyperglycaemia, which is associated with an increased mortality and morbidity risk. Normalising these elevated blood glucose levels by intensive insulin therapy may improve patient outcome, but is associated with an increased risk of hypoglycaemia. The LOGIC-2 study hypothesises that the LOGIC-Insulin computerised software algorithm will allow better (less hyperglycaemia) and safer (less hypoglycaemia) blood glucose control in critically ill patients than nurse-directed blood glucose control.

Conditions

Interventions

DEVICE

LOGIC-Insulin algorithm

DEVICE

Paper protocol

Sponsors & Collaborators

  • Agentschap voor Innovatie door Wetenschap en Technologie

    collaborator OTHER

  • KU Leuven

    lead OTHER

Principal Investigators

  • Dieter Mesotten, MD, PhD · KU Leuven

  • Greet Van den Berghe, MD, PhD · KU Leuven

  • Jasperina Dubois, MD · Jessa hospital, Hasselt

  • Marcus Schultz, MD, PhD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-04-30
Completion
2015-08-31

Countries

  • Belgium
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02056353 on ClinicalTrials.gov